| 產(chǎn)品名稱 |
Bovine herpesvirus 1 |
| 商品貨號(hào) |
B220548 |
| Classification |
Herpesviridae, Varicellovirus |
| Deposited As |
Infectious bovine rhinotracheitis |
| Agent |
Bovine herpesvirus 1 |
| Strain |
IBRV (NG) dltk |
| Common Name |
Infectious bovine rhinotracheitis virus, Bovine rhinotracheitis virus |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Genetically enginered derivative of IBRV-B8-D53 (VR-2066) |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Effect on Host |
Cytopathic effects in tissue culture |
| Recommended Host |
rabbit skin fibroblasts RAB-9 cells (ATCC CRL-1414); MDBK cells (ATCC CCL-22); EBTr cells (ATCC CCL-44); BT cells (ATCC CRL-1390) |
| Growth Conditions |
Temperature: 34.5°C Incubation: 3-5 days |
| Name of Depositor |
NovaGene, Inc., Baylor College of Medicine |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Genetically enginered derivative of IBRV-B8-D53 (VR-2066) |
| References |
Kit M, Kit S. Thymidine kinase deletion mutants of bovine herpesvirus-1. US Patent 4,703,011 dated Oct 27 1987
Kit S, et al. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch. Virol. 86: 63-83, 1985. PubMed: 2994602
Kit S, et al. Intramuscular and intravaginal vaccination of pregnant cows with thymidine kinase-negative, temperature-resistant infectious bovine rhinotracheitis virus (bovine herpes virus 1). Vaccine 4: 55-61, 1986. PubMed: 3008461
|
